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Abstract
Background Following tilt-induced syncope, blood pres-
sure usually recovers rapidly after tilt back to the horizontal
position. However, in some patients, hemodynamic recovery
is delayed, a condition recently termed ‘‘prolonged post-
faint hypotension’’ (PPFH). The mechanism is thought
to be mediated by increased vagal outflow rather than
exaggerated peripheral vasodilatation and sympathetic
withdrawal. To date, no muscle sympathetic nerve activity
(MSNA) recordings have been reported in this condition,
so we aimed to confirm that neither vasodilatation nor
MSNA withdrawal was responsible.
Objectives To retrospectively select patients with satis-
factory recordings of continuous BP and MSNA during tilt-
induced syncope. To compare hemodynamic and MSNA
profiles in patients with PPFH to patients with normal
recovery (NR) after tilt-back.
Methods All patients were studied in Christchurch, New
Zealand, between 1998 and 2008 using continuous arterial
BP monitoring, and microneurographic recordings of
MSNA from the right leg. Only patients with satisfactory
BP and MSNA data throughout baseline, head-up tilt and
presyncope were selected. Stroke volume (SV), cardiac
output (CO), and total peripheral resistance (TPR) were
derived using Modelflow. After baseline measurements,
patients were tilted to the head-up 60 position and given
GTN spray if asymptomatic after 20 min. Following the
onset of presyncope, patients were tilted slowly back to the
horizontal. PPFH was defined as systolic BP \85 mmHg
for at least 2 min after tilt-back. Measurements were
averaged at baseline, early tilt, presyncope, early and late
recovery. Within-group comparisons were made between
baseline and all other time points. Between-group com-
parisons were made over all time points.
Results Patients with PPFH (7 males, age 46 ± 5 years,
n = 8) and with NR (8 males, age 47 ± 6 years, n = 8)
were selected. Presyncope was provoked by GTN in 4/8
patients in each group. In both groups, MAP remained
below baseline during early and late recovery: PPFH
84 ± 5 versus 51 ± 5 and 64 ± 5 mmHg (p = 0.001,
p = 0.001); NR 104 ± 5 versus 83 ± 5 and 93 ± 5
mmHg (p = 0.001, p = 0.03). However, MAP and HR
were lower in the PPFH group (p = 0.004, p = 0.023).
During early recovery, CO remained below baseline only
in the PPFH group (p = 0.001), whereas TPR remained
constant in both groups. In both groups, all MSNA indices
tended to remain above baseline levels during early and
late recovery. PPFH 25 ± 2 increased to 31 ± 6 and
29 ± 4 bursts/min (p = 0.09, 0.02); NR 23 ± 3 increased
to 33 ± 3 and 34 ± 3 bursts/min (p = 0.06, 0.01).
Conclusions PPFH does not appear to be mediated by
exaggerated vasodilatation or sympathetic withdrawal.
Delayed recovery of cardiac output by increased vagal
outflow is a more likely mechanism.
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Introduction
Until recently, the mechanism of vasovagal syncope was
thought to be dual, vasodilatation mediated by sympathetic
withdrawal and bradycardia mediated by vagal activation [1].
The concept of sudden reduction of sympathetic activity
during faint causing relaxation of the blood vessels was based
on plethysmographic demonstration of forearm vasodilatation
[2–4], and microneurographic recordings showing with-
drawal of muscle sympathetic nerve activity (MSNA) in the
leg [5–9]. MSNA is considered to be a major determinant of
rapid changes in total peripheral resistance (TPR) [10, 11].
Despite these important findings, other studies found that
peripheral vasodilatation was not generalized and probably a
terminal event in the time-course of the vasovagal reaction.
Invasive studies [12–15] demonstrated that hypotension dur-
ing presyncope was initiated by a fall in cardiac output which
began up to 5 min before syncope. Continuous finger-pulse
BP monitoring with Modelflow, confirmed that a gradual fall
in cardiac output, secondary to stroke volume decay mediated
progressive hypotension during presyncope [16]. This was
consistent with the observation that presyncope could be
rapidly reversed by maneuvers, which increased venous return
and stroke volume [17, 18]. Therefore, decreasing cardiac
output is clearly important in the sequence of hemodynamic
changes before vasovagal syncope. Recently, Wieling et al.
[19] described a new group of patients with a history of severe
fainting. Continuous BP monitoring during tilt-induced syn-
cope demonstrated prolonged post faint hypotension (PPFH)
and the mechanism for this appeared to be mainly delayed
recovery of cardiac output and reduced left ventricular con-
tractility. TPR was maintained throughout the faint and so
even in PPFH patients with severe fainting, no peripheral
sympathetic withdrawal was found. So far, no MSNA mea-
surements have been performed in PPFH patients. We
hypothesized that because TPR was maintained during PPFH,
MSNA would also remain increased from baseline values. We
also hypothesized that PPFH patients might have lower resting
TPR and MSNA levels compared to NR patients, predisposing
them to more severe episodes of VVS.
Methods
Study population and protocol
We reviewed hemodynamic data from 340 recordings of
tilt tests undertaken in the Christchurch Hospital Syncope
Clinic from 1995 to 2005. All patients had a history of
vasovagal symptoms over the 6 months before tilt. Of
these, 203 tilt tests were positive. A positive tilt test was
defined as a progressive fall in systolic blood pressure
(SBP) below 100 mmHg associated with symptoms of
impending syncope. PPFH, defined as SBP\85 mmHg for
at least 2 min after tilt back was found in 25 patients (7.4%
of tilt tests). From this group, on the basis of satisfactory
MSNA recordings during tilt and presyncope (see below),
we selected eight PPFH patients, (7 males, age 46 ± 5
years). Nearly all had mild bradycardia during late recov-
ery (in 7 out of 8, HR fell below 60 bpm). However, only
two of our PPFH patients had severe bradycardia (HR less
than 50 bpm) as in the group described by Wieling et al.
[19]. A further eight patients with satisfactory MSNA
recordings and normal recovery (NR) of blood pressure
after tilt-induced syncope were selected as controls (8
males, age 47 ± 6 years). Patients were included in the NR
group provided SBP increased to [85 mmHg during the
first 2 min of recovery.
Passive head-up tilt (HUT) to 60o was performed on a
hydraulic tilt-table between 9:00 AM and 1:00 PM in a
temperature-controlled room (23C) according to the Ital-
ian protocol [20]. If presyncope did not occur within
20 min, nitroglycerine (0.4 mg) was administered sublin-
gually. When a progressive fall in blood pressure occurred,
associated with prodromal symptoms, the patient was tilted
slowly back to the horizontal over 20 s.
This study was approved by the Canterbury Hospital
Ethics Committee.
Data acquisition and analysis
Microneurography needles were positioned for recording
MSNA from the right peroneal nerve [21]. The nerve was
located behind the head of the fibula, and, with the use of
transcutaneous stimulation, an insulated tungsten electrode
with a 1- to 5-lm tip was inserted. The nerve signal was
amplified (1,00,0009) filtered (700–2,000 Hz), integrated
(time constant 0.1 ms), and displayed online with blood
pressure and ECG. Bursts of sympathetic activity were
indentified and counted each minute (bs/min) by the same
operator (DLJ). The nerve signal was accepted if the fol-
lowing criteria were met: the signal-to-background ratio
was greater than 3; the bursts were pulse-synchronous;
burst amplitude was inversely proportional to diastolic BP;
and skin activity was absent. It is difficult to maintain the
recording field during recovery following the tilt-back
procedure particularly when patients are severely hypo-
tensive and symptomatic. Therefore, although we were
able to maintain MSNA recordings throughout recovery in
all of the selected NR patients, we only achieved this in
50% of the PPFH group.
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Non-invasive beat-to-beat BP was measured at the fin-
ger (Finometer Blood Pressure Monitor) with the hand held
at heart level in a sling. Invasive BP recordings were
undertaken from a 3 French brachial arterial line with a
deltrans transducer fixed at mid-atrial level. The measured
signal was analogue to digital converted at 200 Hz, and
stored on a hard disk for offline analysis. Systolic (SYS)
and diastolic (DIAS) arterial pressures were derived from
the arterial pressure waveform. Mean arterial pressure
(MAP) was calculated from the integral of the arterial
pressure wave over one beat divided by the corresponding
beat interval. Heart rate (HR) was computed as the inverse
of the inter-beat interval and expressed as beats per minute.
Beat-to-beat changes in stroke volume (SV) were estimated
by modeling flow from the arterial pressure waveform
(Modelflow, TNO Biomedical Instrumentation), expressed
in ml [22]. Cardiac output (CO), expressed in l/min, was
the product of estimated SV and HR. Total Peripheral
Resistance (TPR), expressed in mmHg s/ml, as Medical
units (MU) was derived from MAP divided by the com-
puted CO. The Modelflow method estimates aortic flow
from finger arterial pressure by simulating a non-linear
model of the aortic input impedance [23]. This pulse wave
analysis method corrects for individual differences in age,
gender, height and weight, permitting group average data
to be examined accurately in subjects without structural or
functional heart disease [24]. Previous head-up tilt exper-
iments have demonstrated good agreement between Mod-
elflow and traditional estimates of CO [25, 26].
Sampling of time intervals
For each interval, hemodynamic variables were initially
averaged over 30-s periods and then averaged (2 9 30 s
periods for each minute) for statistical testing. MSNA
variables were initially counted and measured over 60-s
periods. Values for all variables are expressed as
mean ± SE.
The following time intervals were analyzed:
1. Baseline: the last 5 min in the supine position before
head-up tilt
2. Early HUT: the steady-state adjustment to orthostatic
stress during the 1–3 min of HUT (60–180 s).
3. Presyncope: the last minute before tilt-back to the
horizontal position.
4. Recovery: 0–2 and 4–5 min following tilt-back to the
horizontal position.
Statistical analysis
Statistical analysis was performed using unpaired t tests
and v2 tests for demography and baseline variables.
Changes in variables with time were analyzed using one-
way ANOVA for within-group and two-way ANOVA for
between-group comparisons.
Results (see Table 1 and Figs. 1, 2, 3)
All patients had satisfactory MSNA data during tilt and
presyncope, but 4/8 in the PPFH group had incomplete data
during recovery. The groups were matched for age and
gender. Four patients with PPFH (and 2 with NR) had a
life-long history of syncope associated with blood phobia
(p = 0.6). Five PPFH patients reported protracted symp-
toms after fainting (feeling unwell for more than 6 h). Tilt
time and requirement for GTN provocation were similar
between groups.
Between group comparisons of haemodynamic param-
eters across all time points showed that MAP (p = 0.004),
and HR (p = 0.023) were lower in the in the PPFH group
whereas SV was higher (p = 0.037). For all other vari-
ables, including CO (p = 0.89) and TPR (p = 0.128) and
indices of MSNA (bursts/min p = 0.77, bursts/100b
p = 0.65, and burst area/min p = 0.78) there were no
significant differences between groups.
Baseline
Between groups, the PPFH group had lower baseline BP
and TPR than the NR group: MAP 84 ± 4 versus
Table 1 Patient characteristics and baseline hemodynamics
Variable PPFH (n = 8) NR (n = 8) p
Age (years) 46 ± 5 47 ± 6 1.0
Gender (m) 7 8 1.0
Blood phobia 4 2 0.6
Syncopes per year 2 ± 0.7 2.8 ± 0.8 0.5
Tilt time (min) 18.5 ± 2 20.3 ± 3 0.6
GTN 4 4 1.0
MAP (mmHg) 84 ± 4 104 ± 5 0.01
HR (bpm) 59 ± 2 73 ± 6 0.07
SV (ml) 102 ± 8 77 ± 8 0.05
CO (l/min) 5.9 ± 0.5 5.5 ± 0.5 0.59
TPR (MU) 0.9 ± 0.1 1.4 ± 0.2 0.05
MSNA (bursts/min) 25 ± 2 23 ± 3 0.8
MSNA (bursts/100b) 43 ± 4 35 ± 7 0.2
Mean ± SE for demographics and baseline variables. All values
quoted without units refer to absolute counts
PPFH prolonged post-faint hypotension, NR normal recovery, GTN
glyceryl trinitrate given at 20 min head-up tilt, tilt time time tilted up
before presyncope, MAP mean arterial pressure, HR heart rate, SV
stroke volume, CO cardiac output, TPR total peripheral resistance,
MSNA muscle sympathetic nerve activity
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104 ± 5 mmHg (p = 0.012); TPR 0.92 ± 0.1 versus 1.4 ±
0.3MU (p = 0.049), whereas SV was higher: 103 ± 10
versus 77 ± 4 ml (p = 0.046). HR, CO and all indices of
MSNA were similar.
Early HUT
In the PPFH group MAP and HR increased to 92 ± 5
mmHg (p = 0.043) and 66 ± 2 bpm (p = 0.006) respec-
tively, while SV and CO decreased to 75 ml and 4.9 l/min
(p = 0.004, p = 0.004). TPR tended to increase from
0.92 ± 0.1 to 1.2 ± 0.1MU (p = 0.15). In the NR group,
MAP remained constant at 108 ± 5 mmHg (p = 0.2),
while HR increased to 84 ± 6 bpm (0.02). SV and CO
decreased to 54 ± 6 ml (p = 0.004) and 4.3 ± 0.4 l/min
(p = 0.02) while TPR tended to increase (p = 0.1). MSNA
indices increased in both groups: PPFH 25 ± 2 to 44 ± 3
bursts/min (p = 0.001), 43 ± 4 to 75 ± 4 bursts/100beats
(p = 0.001) and 100 to 154 ± 7% burst area (p = 0.001);
NR 23 ± 3 to 41 ± 4 bursts/min (p = 0.001), 35 ± 7 to
59 ± 8 bursts/100beats (p = 0.001) and 100 to 170 ±
13% burst area (p = 0.001).
Presyncope (last minute before tilt back)
MAP fell below baseline levels in both groups: PPFH
68 ± 7 (p = 0.045) and NR 70 ± 7 mmHg (p = 0.002).
In the PPFH group HR increased to 75 ± 6 bpm
(p = 0.027), SV fell to 54 ml (p = 0.003), and CO to 4.0 l/
min (p = 0.002). In the NR group, SV fell further from
baseline to 51 ml (p = 0.012). MSNA indices began to fall
but remained above baseline levels in both groups: PPFH
Fig. 1 Mean and standard error for mean arterial pressure and heart
rate at baseline, early tilt, presyncope, early and late recovery in
patients with prolonged post-faint hypotension (PPFH filled circles)
and patients with normal recovery (NR open circles). Asterisks and
dagger refer to p \ 0.05 and p \ 0.01 for within-group comparisons
to baseline
Fig. 2 Mean and standard error for stroke volume, cardiac output and
total peripheral resistance at baseline, early tilt, presyncope, early and
late recovery in patients with prolonged post-faint hypotension (PPFH
filled circles) and patients with normal recovery (NR open circles).
Asterisks and dagger refer to p \ 0.05 and p \ 0.01 for within-group
comparisons to baseline
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38 ± 5 bursts/min (p = 0.03), 65 ± 11 bursts/100 beats
(p = 0.04), and 149 ± 21% burst area (p = 0.06); NR
38 ± 5 bursts/min (p = 0.01), 51 ± 10 bursts/100 beats
(p = 0.03) and 157 ± 20% burst area (p = 0.02).
Early recovery
In both groups, MAP remained below baseline: PPFH
51 ± 5 (p = 0.001) and NR 83 ± 5 mmHg (p = 0.001). In
the PPFH group, HR fell to baseline at 56 bpm (p = 0.24),
while SV and CO remained below baseline at 69 ± 6 ml
(p = 0.009) and 3.7 ± 0.5 l/min (p = 0.001). In the NR
group SV began to increase but remained below baseline at
62 ml (p = 0.049). All MSNA indices returned to baseline
levels in both groups. PPFH 31 ± 6 bursts/min (p = 0.09),
52 ± 11 bursts/100 beats (p = 0.11) and 133 ± 13% burst
area (p = 0.16); NR 33 ± 3 bursts/min (p = 0.06), 43 ± 7
bursts/100 beats (p = 0.25), 129 ± 19% burst area (p =
0.16).
Late recovery
MAP remained below baseline in both groups: 64 ± 5 and
93 ± 5 mmHg, respectively (p = 0.001, p = 0.03). In the
PPFH group, SV recovered but CO remained below base-
line at 88 ± 6 ml (p = 0.178) and 4.6 l/min (p = 0.049),
respectively. In the NR group, SV increased back to
baseline: 65 ml (p = 0.127). MSNA indices remained at or
above baseline levels in both groups. PPFH 29 ± 4 bursts/
min (p = 0.02), 48 ± 7 bursts/100 beats (p = 0.05),
133 ± 13% burst area (p = 0.08) and NR 34 ± 3 bursts/
min (p = 0.01), 45 ± 8 bursts/100 beats (p = 0.09),
119 ± 10% burst area (p = 0.09).
In summary, MAP and HR were lower at baseline and
during recovery in the PPFH group. We also observed that
unlike the NR group, CO was depressed through recovery
in the PPFH group. Although TPR was lower in the PPFH
group at baseline, this was not apparent during recovery
and exaggerated MSNA withdrawal was not seen.
Discussion
Our hypothesis, that MSNA would remain increased from
baseline values during PPFH, is supported by our findings.
TPR remained constant at baseline levels in both groups,
while MSNA tended to be elevated. Thus although blood
pressure was clearly lower in the PPFH group during
recovery, it did not appear to be mediated by an exagger-
ated withdrawal of MSNA. Delayed recovery of CO and a
lower HR throughout recovery secondary to increased
vagal outflow is therefore the most likely mechanism for
PPFH. These results are consistent with the findings of
Wieling et al. [19] who first described PPFH in a group of
seven patients during HUT. Wieling concluded that
decreased LV contractility, secondary to exaggerated vagal
activity was responsible for PPFH. Like his patients, ours
were predominantly middle-aged males, with low-normal
resting BP, some of whom had blood phobia. Unfortu-
nately, our methods for deriving SV, CO and TPR did not
allow reliable comparisons of baseline levels so we are
uncertain as to the hemodynamic mechanism for the low-
normal resting BP in the PPFH group. Although MSNA is
an important determinant of TPR in the dynamic setting
[10], the relationship between MSNA and TPR at rest is
Fig. 3 Mean and standard error for MSNA burst frequency, burst
incidence and burst area at baseline, early tilt, presyncope, early and
late recovery in patients with prolonged post-faint hypotension (PPFH
filled circles) and patients with normal recovery (NR open circles).
Asterisks and dagger refer to p \ 0.05 and p \ 0.01 for within-group
comparisons to baseline
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more complicated, particularly with increasing age [27].
We measured similar MSNA levels in the two groups at
baseline and throughout tilt, therefore, we think TPR was
unlikely to be lower in the PPFH group. Therefore, our data
do not support the hypothesis that PPFH patients have low
resting TPR, nor impaired sympatho-vasoconstriction pre-
disposing them to VVS [8, 28].
Even though MSNA has been studied extensively during
tilt and presyncope [5–8, 28, 30], few studies include
MSNA during recovery [13, 30]. This is because it is
technically very difficult to maintain a satisfactory nerve
recording field during the course of presyncope and
recovery. The recording electrode may be dislodged by
muscle tensing, myoclonic leg movements or the tilt-back
maneuver. In some studies, the resulting decrease in burst
frequency or size may have been falsely interpreted as
sympathetic withdrawal [31]. The only way to be sure that
a field has been maintained throughout presyncope is to
observe spontaneous recovery of the bursting pattern after
tilt-back without adjusting the recording electrode [8].
Although MSNA remained well above baseline during
presyncope, we observed a terminal fall-off in MSNA
immediately before tilt-back in both groups. This data
confirms previous studies showing that provided patients
became sufficiently hypotensive, some degree of sympa-
thetic withdrawal usually occurred during the final seconds
of presyncope before tilt-back [5, 8, 13, 28]. This is partly
because individual bursts of MSNA are gated to the dia-
stolic phase of the cardiac cycle and when heart rate
decreases, burst rate follows [32]. Two recent studies have
contested this finding [29, 31].We observed that the
decrease in MSNA burst rate was not totally dependent on
bradycardia because burst incidence usually decreased in
unison with burst rate. For ethical reasons, and to decrease
the risk of losing the recording field, patients were tilted
back to the horizontal before bradycardia and complete
sympathetic withdrawal ensued. Consequently, we dem-
onstrated only partial sympathetic withdrawal at tilt-back
and thereafter, maintenance of MSNA at or above baseline
levels during recovery. We are uncertain as to why MSNA
was not higher in the PPFH group at this time and cannot
exclude some degree of central sympathetic depression.
Nevertheless, our data demonstrated delayed recovery of
CO and lower HR in the PPFH group, which implies that
this is the most likely mechanism responsible. Therefore,
doctors with a specialist interest in syncope should be
aware that a minority of fainters (7.4% in this study and
1.9% in the study by Wieling et al. [19] may exhibit PPFH,
for example during tilt-testing and so will require moni-
toring and rest in the horizontal position for an extended
recovery period. This phenomenon seems to be secondary
to a transient vagal-induced paresis of the left ventricle
[19], which is a fascinating and novel physiological
prospect. We predict that passive leg raising, a manoeuvre
that rapidly increases venous return, will not decrease
recovery time during PPFH. A central stimulation by
‘‘dynamic tension’’ (active bilateral leg flexion and exten-
sion) may be required [19] (Wieling et al. 2012 Case).
Limitations
This is a retrospective study, looking at a relatively small
group of patients, which was limited mainly by technical
difficulties obtaining satisfactory MSNA data. At the time
the recordings were made, we were mainly concerned with
preserving the recording field throughout presyncope, and
so we did not allow our patients to become as bradycardic
as the PPFH group previously reported [19]. This accounts
for the difference in hemodynamics between the two
studies. Nevertheless, this should not detract from our main
finding, that MSNA is not decreased during PPFH. MSNA
recordings, although the best dynamic measure of sym-
patho-vasoconstriction, are all limited to the vascular bed
of one (lower) limb, which may not be representative of the
major resistance/capacitance vessels during vasovagal
syncope [33]. We did not measure lower limb blood flow
and so cannot exclude loss of sympathetic transduction or
active vasodilatation as a possible mechanism for increased
MSNA during PPFH [31].
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